The ARMS variant, which generally has a worse prognosis, harbors pathogenic chromosomal translocations in about 80% of cases, resulting in the expression of PAX3-FOXO1 or PAX7-FOXO1 fusion proteins (Davis et al, 1994). This evidence concerns the gene FOXO1 and alveolar rhabdomyosarcoma.